Chris is a partner at Madrona Venture Group which he joined in 2017. As part of the investment team, Chris is focused on identifying, evaluating, and leading new investment opportunities while working closely with existing companies. Chris spends the majority of his time helping lead Madrona’s investments in companies innovating around the intersection of life and computer science. He is an investor and board member in many life science-focused startups including Modulus Therapeutics, A-Alpha Bio, Ozette, Ovation, and Terray Therapeutics.
Prior to joining Madrona, Chris led finance, business intelligence, and strategy for consumer-focused startup n New York City. While there, Chris led several rounds of fundraising and helped oversee significant growth in the first 18 months of operations. Chris was also on the investment team at Invus – a New York City-based Private Equity firm – where he focused on life science and consumer investing and supporting the earliest stage portfolio companies.